Lexeo Therapeutics (LXEO) Other Non Operating Income (2023 - 2026)
Lexeo Therapeutics (LXEO) reported Other Non Operating Income of -$1000.0 for Q1 2026, up 75.0% on a YoY basis from -$571.43 in Q1 2025, and up 99.98% sequentially from -$5.5 million in Q4 2025.
Lexeo Therapeutics (LXEO) Other Non Operating Income (2023 - 2026) Analysis & Trends
Lexeo Therapeutics (LXEO) has 4 years of Other Non Operating Income data on file, last reported at -$1000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 75.0% year-over-year to -$1000.0; the trailing twelve-month figure through Mar 2026 stood at -$5.5 million (down 912.96% YoY), and the FY2025 full-year result was -$5.5 million, down 914.6% from the prior year.
- Other Non Operating Income rose to -$1000.0 in Q1 2026, from -$5.5 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $687000.0 in Q4 2024 to a low of -$5.5 million in Q4 2025.
- A 4-year average of -$373769.2 and a median of -$4000.0 in 2023 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income soared 9914.29% in 2024 and tumbled 1300.0% in 2025, its largest moves.
- Tracing LXEO's Other Non Operating Income over 4 years: stood at -$7000.0 in 2023, then soared by 9914.29% to $687000.0 in 2024, then sank by 900.0% to -$5.5 million in 2025, then jumped by 99.98% to -$1000.0 in 2026.
- Business Quant data shows LXEO's Other Non Operating Income at -$1000.0 in Q1 2026, -$5.5 million in Q4 2025, and -$9000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Lexeo Therapeutics | 379.94 Mn | 379.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | -5.50 Mn |
| Sep 30, 2025 | -9,000.00 |
| Jun 30, 2025 | -14,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | 687,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | -3,000.00 |
| Mar 31, 2023 | -4,000.00 |